Validus Reports has released a latest study on Market Report for Eye Care in China - Industry Trends, Analysis, Statistics and Forecasts to 2022. According to the China Food and Drug Administration (CFDA), Hypromellose eye drops were switched from Rx to OTC status at the end of 2016. This ingredient is poised to become a growth engine in standard eye care over the forecast period as many new brands have entered the category.
Interested to know more about this report? Click here to request for a sample.
Our, Market Report for Eye Care in China - Industry Trends, Analysis, Statistics and Forecasts to 2022 offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Eye Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
About Validus Reports:
Validus Reports is a market research aggregator bringing you the most comprehensive research studies, in time and at the best prices.
Contact Us:
In case of additional questions and best prices, write to:
Mr. Trevor Cherian
sales@validusreports.com
Comments
Post a Comment